The Immune-Mediated Inflammatory Disease Forum
The Immune-Mediated Inflammatory Disease Forum is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in immune-mediated inflammatory diseases. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of inflammatory diseases, and its implications for clinical practice.The Forum’s programmes are free from commercial bias and feature leading experts sharing their knowledge and experience in the form of video tutorials. Membership of the Forum is free to everyone. Register as a member and have unlimited free access to all of the materials contained within the site.
- 21:08
- 21 күн бұрын
Author Interview: Dr Adam Goldman, 2024
- 26:44
- Ай бұрын
Author Interview: Professor Daniel Blockmans, 2024
- 23:24
- Ай бұрын
Discussing RA: July 2024
- 22:15
- 2 ай бұрын
Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status
- 26:00
- 2 ай бұрын
Discussing RA: June 2024
- 36:39
- 2 ай бұрын
EULAR 2024 Review Podcast
- 2:45
- 2 ай бұрын
EULAR 2024 Highlights: Day 4
- 4:26
- 2 ай бұрын
EULAR 2024 Highlights: Day 3
- 4:01
- 2 ай бұрын
EULAR 2024 Highlights: Day 2
- 5:10
- 2 ай бұрын
EULAR 2024 Highlights: Day 1
- 14:01
- 2 ай бұрын
EULAR 2024 Preview Podcast
- 30:08
- 2 ай бұрын
Discussing RA: May 2024
- 29:50
- 3 ай бұрын
Discussing PsA: Bimekizumab therapy in PsA
- 33:52
- 3 ай бұрын
IMID Author Interview: Dr Blanca Hernández-Cruz, 2024
- 23:27
- 3 ай бұрын
IMID Author Interview: Dorthe Berthelsen, 2024
- 29:49
- 3 ай бұрын
Discussing AxSpA: Etanercept response & real-world effectiveness of tofacitinib & adalimumab
- 1:29:16
- 3 ай бұрын
Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar
- 21:02
- 3 ай бұрын
IMID Author Interview: Dr Jake Weddell, 2024
- 28:34
- 4 ай бұрын
Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib
- 20:37
- 4 ай бұрын
IMID Author Interview: Professor Frank Verhoeven, 2024
- 11:13
- 4 ай бұрын
Discussing RA: April 2024
- 31:18
- 4 ай бұрын
Author Interview: Professor Dennis McGonagle, 2024
- 33:01
- 4 ай бұрын
Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs
- 32:31
- 5 ай бұрын
Пікірлер